Compare Funko Inc (FNKO) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Funko Inc vs Kymera Therapeutics Inc. Common Stock — how do they compare? Funko Inc trades at $6.31 (market cap $355.57M), while Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 25× Funko Inc's market cap, and Funko Inc is trading nearer its 52-week high, Kymera Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Funko Inc for 33 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| FNKO | KYMR | |
|---|---|---|
Market Cap | $355.57M | $8.88B |
Volume | 738,460 | 1,028,790 |
Sector | Consumer Cyclical | Health |
52-Week High | $7.10 | $127.31 |
52-Week Low | $2.81 | $55.80 |
Typical Hold Time | 33 Days | 0 Days |
Enterprise Value | $576.22M | $8.27B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Funko Inc
Funko Inc is a US-based pop culture consumer products company. It creates whimsical, fun, and different products which enable the customer to express their affinity for their favorite through movie, TV show, video game, musician or sports team. The company holds licenses and the rights to create tens of thousands of characters including Game of Thrones, Walking Dead, Disney, Marvel, Harry Potter, Fallout, and others. Its products include Pop, Dorbz, Mystery Vinyl, Plush, Action Figures, and Others. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites.
Read more on FNKO →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
